Funded Tech Companies
Create Medicines
Wondering who provided funding to Create Medicines? Alexandria Venture Investments, Newpath Partners and Hatteras Venture Partners joined the equity holders in this biopharmaceutical company.
Company Overview
Company Name
Create Medicines
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
300 Technology Square 203
Cambridge, MA 02139
USA
Cambridge, MA 02139
USA
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
CREATE Medicines is pioneering multi-immune programming with its versatile in vivo CAR platform. Our proprietary mRNA-LNP CARs and targeted receptor/LNP technologies enable direct programming of T cells, NK cells, and myeloid cells within the body. CREATE's in vivo CAR products have demonstrated first-in-human evidence of uptake, expression, and tolerable repeat dosing.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
5/14/2026
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Daniel Getts
Chief Financial Officer
Brett Kaplan
Chief Financial Officer
Jason Walsh
Chief Medical Officer
Matthew Maurer
Chief Scientific Officer
Robert Hofmeister
Chief Technical Officer
Jerome Chal
Vice President
Michele Cioffi
Vice President
Heather Cohen
VP - Bus. Development
Adam Raff
VP - Human Resources
Curtis Demick
VP - R & D
Jian Ding
Company Investors
- Alexandria Venture Investments
- Newpath Partners (Tom Thomas)
- Hatteras Venture Partners
- Arch Venture Partners (Brian Cuneo)
Browse more funded tech companies:
Create & Learn | Create Music Group
Share this article
About Our VC & M&A Database
The company data above is provided by VentureDeal.com, a leading supplier of venture capital funding data.
Additional Resources for Entrepreneurs